Amarin Corp. ADR buy fchar99
Summary
This prediction ended on 01.10.18 with a price of €15.45. The BUY prediction by fchar99 for Amarin Corp. ADR saw massive gains of 38.31%. fchar99 has 50% into this predictionAmarin Corporation plc (Symbol AMRN) is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to improve cardiovascular health. The company's main product, Vascepa, is a prescription medication that has been approved by the US FDA for use as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia. Vascepa has also shown to reduce the risk of cardiovascular events such as heart attack and stroke in patients with elevated cardiovascular risk. As a listed company, Amarin is publicly traded on the NASDAQ stock exchange and has a market capitalization of approximately $5 billion as of August 2021.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amarin Corp. ADR | -5.780% | -5.780% | -34.274% | -81.134% |
| iShares Core DAX® | 0.160% | -1.640% | 12.016% | 15.557% |
| iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% | 42.685% |
| iShares Nikkei 225® | -2.519% | -7.621% | 18.066% | 2.904% |
| iShares S&P 500 | -1.377% | -2.809% | 26.536% | 41.689% |
Comments by fchar99 for this prediction
In the thread Amarin Corp. ADR diskutieren
fchar99 agrees with stratec's Buy-prediction
On 09/25/2018, fchar99 agrees with stratec's' Buy-prediction with a target price of $13.0.
Title: Amarin erwartet Top Line Ergebnisse mit Reduce-It Studie